Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies Beyond the Season

Completed

Conditions studied: Influenza

In brief

This a sub-study of a 5-year study designed to investigate how antibody and T cell responses following influenza vaccine compare among lung transplant patients, patients waiting for lung transplantation, and healthy individuals. This study is designed to investigate influenza vaccine-induced antibodies in lung transplant patients beyond the season of vaccination.

Key facts

Study ID

NCT04530786

Run by

University of Wisconsin, Madison

People needed

100

Starts

2004-12-01

Expected to finish

2009-07-01

Last updated by the study team

2020-10-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Receiving care Post-lung transplant at University of Wisconsin Hospital
• Healthy adult

You may not qualify if…

• Allergy to eggs
• Moderate to severe febrile illness
• Active treatment for acute rejection
• Received season's influenza vaccine prior to enrollment

Where it is running

• University of Wisconsin — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.